Health Catalyst Inc
NASDAQ:HCAT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of 
Health Catalyst Inc (HCAT) under the Base Case is 1.75 USD per share.
Compared with the current market price of 1.44 USD, the stock appears
Undervalued by 18% .
The intrinsic value is calculated using the DCF method. Net margin recovers from -57% last year to 1% by 2033. Revenue grows about -10% a year over the next five years, less than a third of its five-year pace of 11%. The forecast years subtract value, so the estimate rests entirely on the years after 2033.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Health Catalyst Does
Health Catalyst makes software and services that help hospitals and health systems organize clinical and financial data, analyze performance, and improve care delivery. Its products pull data from many hospital systems into one place, then turn it into dashboards, reports, and decision support tools that managers and clinicians use to spot inefficiencies, track outcomes, and manage costs.
- Headquarters
- United States of America US
- Employees
- 1 200
- IPO date
- Jul 25, 2019
Revenue & Expenses Breakdown
Health Catalyst Inc
Earnings Waterfall
Health Catalyst Inc
What is the Intrinsic Value of one HCAT stock?
The intrinsic value for Health Catalyst Inc (HCAT) under the Base Case is 1.75 USD.
Is HCAT stock undervalued or overvalued?
Compared with the current market price of 1.44 USD, the stock appears Undervalued by 18% .
